A TSEC for Symptom Management in Menopausal Women With Multiple Sclerosis

Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2016
Duavee is a hormone receptor modulator that has been approved for the treatment of menopausal symptoms in menopausal women. The goal of this 8-week randomized, double blind, placebo controlled pilot study, is to determine whether this medication alleviates menopausal symptoms in women with MS. The investigators will secondarily determine whether addressing menopausal symptoms ameliorates MS symptoms and, on MRIs, is not triggering worsening inflammation.
Epistemonikos ID: 7f3f3b755d043ae8f539a3922701795e1c25c519
First added on: Mar 31, 2022